RetinAI attends OIS Retina Innovation Summit and ASRS 2022 Annual Meeting from July 13th to 16th in New York

Bern, Switzerland, 05th July, 2022

RetinAI Medical AG (“RetinAI”) will attend the OIS Retina Innovation Summit on July 13th at the Edison Ballroom NYC, and the ASRS 2022 Annual Meeting, from July 14th to 16th, at the Javits Convention Center in New York.

On July 13th during the OIS Retina Innovation Summit, RetinAI’s Chief Scientific Officer, Sandro De Zanet, PhD, will hold a presentation to introduce the RetinAI Discovery® platform and our AI models and describe applications on how this technology is being used in Ophthalmology today.
RetinAI is also a sponsor of this important conference in the retina space.

From July 14th to 16th, RetinAI will exhibit at the ASRS 2022 Annual Meeting at the Javits Convention Center in New York. At booth #625, RetinAI’s team will showcase its innovative data management and AI analysis solutions to optimize and simplify clinical development workflows for stakeholders in pharma, research and clinics. ASRS attendees who visit RetinAI at Booth #625 will benefit from learning and seeing live demos on:

  • RetinAI Discovery® platform to accelerate clinical studies. The platform is being used in large-scale clinical studies to effectively collect and manage data at-scale, with real time visibility to data collection and analysis across study stakeholders.
  • RetinAI Discovery® UNITY, an organization’s solution for centralizing its data from multiple data sources and formats to a single unified platform to generate powerful, robust analyses and insights that advance knowledge of disease, patient populations and outcomes.
  • RetinAI’s Disease Evaluation Apps on Heidelberg Engineering’s secure workflow solution, called AppWay, for AI applications will provide valuable, actionable insights for disease and patient management in the clinic.

To learn more on these solutions:

To schedule a live demo at Booth #625 of RetinAI’s solutions and speak with our team, please contact us here.

About OIS Retina Innovation Summit

About ASRS

About RetinAI

RetinAI Medical AG (RetinAI), founded in early 2017, is a Swiss company developing software solutions to enable the right decisions sooner in healthcare, we accelerate clinical, research and pharmaceutical workflows globally using advanced machine learning and computer vision. The company builds tools to collect, organize and analyze health data from the eyes, enabling healthcare professionals to make the right decisions sooner in healthcare. RetinAI's international team combines clinical, technical, and scientific knowledge to foster the transition from reactive to preventive medicine for severe diseases affecting the eye.